Apatinib in combination with docetaxel and S1 chemotherapy in the first-line treatment of metastatic gastric cancer.

4055Background: First-line chemotherapy in metastatic gastric cancer, either doublet or triplet-regiment, the average OS is less than one year. Anti-VEGF target therapy is proven to be effective bo...